Search results for: 'research area cell cycle c myc'
-
B1439 Golvatinib (E7050)Target: VEGFRSummary: C-Met/VEGFR-2 inhibitor
-
A2307 PHA-6657521 CitationTarget: c-METSummary: C-Met inhibitor,potent and ATP-competitive
-
A4171 EPZ0056872 CitationTarget: EZH2Summary: EZH2 inhibitor,potent and selective
-
A3712 PF-04217903 methanesulfonateTarget: c-METSummary: C-Met inhibitor,selective and ATP-competitive
-
A4056 AT13387Target: HSP90Summary: Hsp90 inhibitor
-
A4102 CI994 (Tacedinaline)1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor
-
A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve
-
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-
A1921 Z-DQMD-FMK3 CitationTarget: CaspasesSummary: Caspase-3 inhibitor,cell-permeable
-
A3352 Daun022 CitationSummary: Cell viability inhibitor,DNA synthisis inhibitor